Passion Matters
    Infrastructure
      Institute for Translational Research
        Incubation, Acceleration & Elite
        Funding and Capital
          Corporate Partnerships
          Talent Game On
            TALENT OPPORTUNITIES
            ENTERPRISE OPPORTUNITIES
            Innofacturing Tomorrow
              Tai Po INNOPARK
              Tseung Kwan O INNOPARK
              Yuen Long INNOPARK
              Why Hong Kong
              Greater Bay Area

              Partnership stories

              3 Mar 2023
              China Pharmaceutical Innovation and Research Development Association visits Hong Kong Science Park promoting local and national biomedical development

              18 Jan 2023
              HKSTP and Roche join hands in strategic collaboration leading HK and GBA in pioneering life science innovation in AP, and setting an example for the region

              23 Dec 2022
              OrbusNeich’s IPO serves as a beacon for Hong Kong’s health tech sector, as the first medical device company in Science Park hits major milestone

              12 Dec 2022
              HKSTP, SPH AND BIOPHARMA EVOLUTION CO-LAUNCH BIOMEDICAL TECHNOLOGY CO-INCUBATION PROGRAMM

              9 Nov 2022
              樂齡科技應對人口老化　科技園內初創　展示創新成果

              2 Nov 2022
              樂齡科技博覽開鑼 科技園率45間園區公司參展

              21 Sep 2022
              科技園夥默克發掘生物醫藥初創

              8 Aug 2022
              Driving Biomedical Innovation in Hong Kong

              17 Jun 2022
              科技園與勃林格殷格翰推出計畫 共同培育生物醫藥初創企業

              23 May 2022
              醫療創新| 科學園兩夥伴企業硏發抗癌藥 晚期癌症有望轉為慢性病

              Park company stories

              10 Nov 2022
              英矽智能夥賽諾菲研發藥物 藉AI跨學科合作 潛在價值達94億

              22 Aug 2022
              繼新冠口服藥及抗衰老研究後再取得突破 科技園夥伴英矽智能以AI破解「漸凍症」

              5 Aug 2022
              【生物科技】漸凍症不再是絕症？　英矽智能研AI平台分析數據　發現潛在治療靶點

              1 Jul 2022
              ‘Monumental’ call: Hong Kong can be China’s international I&T hub, Xi Jinping says on visit to city’s Science Park

              13 Apr 2022
              Why Hong Kong’s biotech funding boom can have positive impact on start-ups and community

              19 Jan 2022
              AI藥物研發加快 英矽智能與復星合作

              ITR & InnoHK

              24 Jan 2024
              SHANGHAI PHARMACEUTICALS HONG KONG-SHANGHAI CO-INCUBATOR “01LABS@HONG KONG” OPENS AT SCIENCE PARK

              29 Dec 2023
              Forever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion market

              27 Dec 2023
              HKSTP Applauds HighTide Therapeutics' IPO and First Clinical Trial Development in the City for the Innovative Treatment of Nonalcoholic Steatohepatitis (NASH) in Advancing Hong Kong’s Biotech Ecosystem

              12 Dec 2023
              Simcere Pharmaceutical Opens ‘Hong Kong Collaborative Innovation Center’ Accelerating R&D and Translation of Innovative Drugs

              6 Dec 2023
              Over 800 local and international academics and scientists attended the InnoHK Summit 2023

              02 Dec 2023
              PHASE 1 CLINICAL TRIAL APPROVED BY FDA – INNORNA’s FIRST-IN-CLASS MRNA VACCINE IN001 TREATING HERPES ZOSTER COMMONLY KNOWN AS SHINGLES

              24 Nov 2023
              HKSTP Tackles Hong Kong’s Critical Ageing Society Challenge at Gerontech and Innovation Expo cum Summit (GIES) 2023

              14 Nov 2023
              HIFIBIO’s HFB200301 obtained IND approval by NMPA and the drug discovery platform obtained AI Innovation of the Year at the 2023 BioTech Breakthrough Awards!

              10 Nov 2023
              HKSTP Welcomes Forever Cheer Holding’s R&D Headquarters for Groundbreaking Pain Management Drug to Science Park

              8 Nov 2023
              HKSTP Celebrates the Success of Park Companies and Incubatees on Winning 27 Awards at the 2023 Hong Kong ICT Awards

              23 Oct 2023
              Grid Biosciences becomes Hong Kong’s first company to partner with the International Vaccine Institute – an initiative of the United Nations.

              18 Oct 2023
              HKSTP and WuXi XDC Join Forces to Promote Development of Bioconjugate Drug Industry in Hong Kong

              13 Oct 2023
              Insilico Medicine has signed a worldwide licence-out agreement with USD80M upfront with listed pharmaceutical firm Exelixis to develop and commercialise ISM3091, an AI-designed oral drug for BRCA-mutant cancers.

              13 Oct 2023
              InxMed 应世生物 has obtained approval from China’s National Medical Products Administration to carry out clinical trials for OMTX705, an antibody drug conjugate (ADC) targeting advanced solid tumour in this area.

              13 Oct 2023
              HiFiBiO Therapeutics, backed by HKSTP Venture Fund, has been named one of the 2023 “Fierce 15” #BioTech companies!

              26 Sep 2023
              HKSTP and Hospital Authority Establish Data Collaboration Lab at Science Park to Enable Industry Access to Clinical Big Data

              21 Sep 2023
              Sirnaomics Group Moves into Hong Kong Science Park to Jointly Write a New Chapter for Biomedicine Development in Hong Kong

              21 Sep 2023
              Establishment of MGI's Lab at Hong Kong Science Park to expand its global R&D footprint

              20 Sep 2023
              HKSTP Showcases City’s Biotech Ecosystem as a Platform for French Entrepreneurs to Scale and Go Global

              13 Sep 2023
              Our “super connector” branch just opened in Shenzhen, marking a new innovation gateway and powerhouse in the GBA.

              25 Aug 2023
              HKSTP Partner Company HVB: Frontier to Develop Retinal Image Analysis for Health Risk Assessment in Companion Animals

              18 Aug 2023
              HKSTP and DH sign MOU to drive digital transformation in public health

              11 Aug 2023
              HKSTP and MSD Join Hands to Empower Data-Driven Solutions for the Pharmaceutical Industry

              28 Jul 2023
              Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA

              21 Jul 2023
              HKSTP Partner Companies HKRM and Cordlife Sign Collaboration Agreement To Advance Stem Cell Therapy and Improve Awareness of Regenerative Medicine

              Hong Kong Regen Medtech Limited HKRM is partnering with Cordlife Group Limited Hong Kong

              20 Jul 2023
              幹細胞治療｜臍帶提取幹細胞外泌體 有望治療退化性關節炎 料兩年內完成動物測試

              20 Jul 2023
              HKSTP Park Company Beijing Huarene Biotechnology Secures Strategic Investment in Major Boost to Hong Kong’s Biotech Innovation Ecosystem

              11 Jul 2023
              中大研究證實「血漿DNA」篩查能偵測到早期沒有病徵的鼻咽癌 並反映日後患鼻咽癌風險

              1 Mar 2023
              Secretary of the Innovation, Technology and Industry Bureau introduced the latest HK I&T development to JLABS Asia Pacific team.

              4 Jul 2023
              Huge congratulations to Insilico, on completing its first patient dose for INS018_055! Marking the second major clinical milestone in just 6 months.

              27 Feb 2023
              Secretary of the Innovation, Technology and Industry Bureau introduced the latest HK I&T development to the delegation of China Pharmaceutical Innovation and Research Development Association.

              First drug discovered and designed with generative AI enters Phase II trials, with first patients dosed

              27 Feb 2023
              HKSTP and Roche forge strategic collaboration to spur life science innovation and build hub

              26 Jun 2023
              HKSTP Congratulates Prenetics and Renowned Scientist Professor Dennis Lo on its US$200m Joint Venture for Multi-Cancer Early Detection as a Defining Moment for Hong Kong’s Role as Biomedical Technology Hub

              26 Feb 2023
              Financial Secretary was impressed by Ecoinno’s zero plastic disposable tableware, which is produced from Ecoinno’s unique plant fiber based technology. Biotech promotes sustainability!

              21 Jun 2023
              Immuno Cure Kicks off Phase IIa Clinical Trial in Hong Kong

              8 Feb 2023
              Insilico Medicine has received FDA Orphan Drug Designation (ODD) for its AI-discovered drug (INS018_055) to treat rare chronic lung disease, Idiopathic Pulmonary Fibrosis (IPF)!

              15 Jun 2023
              HKSTP and CUHK open a new ATP GMP Centre to fast-track the cell and gene therapy (CGT) manufacturing industry in Hong Kong and the GBA

              18 Jan 2023
              Two Science Park companies launch health management platform

              13 Jun 2023
              Gleneagles Hospital Hong Kong Signs Collaboration Agreement with HKSTP to Drive Cutting-Edge Innovation and Advance Patient Care

              12 Jan 2023
              AZ-CICC Healthcare Fund - a joint investment

              13 Jun 2023
              Sirnaomics's leading RNAi therapeutics (STP122G) has entered its FDA-approved Phase I clinical trial to target unmet blood clotting-related disorders!

              12 Jan 2022
              Who would’ve thought that as many as 81 types of gut microbiota are linked to Long COVID?

              24 May 2023
              HKSTP and HKU Collaborate to Establish State-of-the-Art PIC/S GMP Facility for Advanced Cell Therapies

              13 Oct 2022
              Hong Kong’s next era fuelled by innovation

              23 May 2023
              港大與科技園合作成立「細胞治療實驗室」　發展療法助心血管病及血癌患者

              A Healthy Future

              19 May 2023
              HKSTP Joins the City’s Healthcare Flagship Events to Drive Tech Adoption and Help Advance the Government Primary Healthcare Blueprint

              中大學者盧煜明奪美國「拉斯克獎」

              20 Apr 2023
              BioMed Technology Funded by Alibaba Hong Kong Entrepreneurs Fund, Gobi and TIMC to Realise Precision and Personalised Gut Microbiome Management for Wellness

              科大發現阿爾茲海默症發病機制關鍵　有助研發更簡單安全治療策略

              19 Apr 2023
              HKSTP and The Hong Kong Medical Association Reinforce Partnership and Mission to Strengthen Primary Healthcare with Technology

              Fighting Alzheimer's disease: Hong Kong's Science and Technology Parks

              4 Apr 2023
              HKSTP and AstraZeneca signing MOU on Strategic Collaboration

              應科院夥InnoHK眼視學中心 研AR治療視障者

              17 Mar 2023
              香港科技園公司代表團訪問上海 促進滬港生物醫藥科技創新轉化合作

              Immuno Cure is making history as its newfound therapeutic vaccine for HIV has got approval from China's National Medical Products Administration (NMPA) to conduct phase 1 clinical trial!

              16 Mar 2023
              Time Medical Officially Opens New Hong Kong Production Facility at Tai Po MARS Centre

              HiFiBiO Therapeutics has received its 3rd FDA Investigational New Drug (IND) clearance, this time for its novel anti-BTLA monoclonal antibody (HFB200603) to target DIS™ selected solid tumours.

              14 Mar 2023
              FDA-cleared Belun Sleep System may speed up OSA diagnosis for 1 billion population

              We use cookies to ensure that we give you the best experience on our website. We also share information about your use of our site with our social media and analytics partners. By continuing to use our website, you agree to our use of such cookies. For more information, please review our Cookies Policy and Privacy Policy.